May 14, 2021
“GlycoMimetics (GLYC)… To this end, Jallah rates GLYC a Buy along with a $15 price target. Shares could appreciate by 567%, should the analyst’s thesis play out in the coming months… The company’s progress has attracted 3 unanimous positive reviews… Continue Reading…
April 29, 2021
“Compass, Inc. (COMP)… After less than month in the public markets, Compass has already picked up 9 analyst reviews. These break down to 5 Buys and 4 Holds, giving the stock a Moderate Buy analyst consensus rating. The average price… Continue Reading…
April 13, 2021
“CTO Realty Growth (CTO)… Overall, CTO has 3 reviews on record from Wall Street’s analysts, and they all agree that this stock is a Buy, making the analyst consensus of Strong Buy unanimous. The shares are priced at $41.85, and their… Continue Reading…
April 12, 2021
“Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist? Boeing (BA), Floor & Decor (FND), Target (TGT) Scotts Miracle-Gro (SMG) and the VanEck Vectors Semiconductor ETF… Continue Reading…
April 1, 2021
“PaySign, Inc. (PAYS) I’m liking the double bottom chart pattern that, as of the time I was writing this column, hadn’t yet come to fruition (i.e., turned into an uptrend) for PaySign, Inc. (PAYS). But this, combined with some positive newsflow regarding… Continue Reading…
March 31, 2021
“Savara, Inc. (SVRA)… Overall, SVRA has 3 recent analyst reviews, and all are Buys, making the analyst consensus rating a Strong Buy. The average price target stands tall at $4.67, which suggests the stock has room for 173% upside in the… Continue Reading…
March 25, 2021
“Oncolytics Biotech (ONCY)… Turning now to the rest of the Street, other analysts are on the same page. With 5 Buys and no Holds or Sells, the word on the Street is that ONCY is a Strong Buy. Given its… Continue Reading…
March 23, 2021
“Nuance Communications (NUAN)… Ives is no outlier on Nuance, as shown by the unanimous Strong Buy analyst consensus on the stock. Nuance has received 6 recent reviews, and all are to Buy. The shares are trading for $45.20, and the $59.67… Continue Reading…
March 23, 2021
“Iovance Biotherapeutics (IOVA)… The cutting edge med tech has attracted attention from Pantginis’ colleagues, as well. The stock has 5 recent reviews, and all are to Buy, making for a unanimous Strong Buy analyst consensus rating. IOVA has an average… Continue Reading…
March 22, 2021
“…Google parent Alphabet (GOOGL), CarMax (KMX), Regal Beloit (RBC), Westlake Chemical (WLK) and Applied Materials (AMAT) are prime candidates… Now is a good time to get back into the market, but caution should be exercised. While the market uptrend has resumed, the stock market has just had a modestly down week.… Continue Reading…
Recent Comments